Transcriptional Effectors of Activated RAS Signaling in Juvenile Myelomonocytic Leukemia |
Boston Children's Hospital / Alan Cantor, MD, PhD |
Innovation Grants |
2015 |
Massachusetts |
Single Cell Analysis of Leukemia Initiation |
Stanford University / Michael Cleary, MD |
Innovation Grants |
2015 |
California |
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma |
Virginia Commonwealth University / Anthony Faber, MD & Yael Mosse, MD (CHOP) |
Innovation Grants |
2015 |
Virginia |
Preclinical Development of Atr Inhibitor VE-822, Delivered Systemically in Nanoparticles, for Medulloblastoma Therapy |
University of North Carolina / Timothy Gershon, MD, PhD |
Innovation Grants |
2015 |
North Carolina |
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children's Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD |
Innovation Grants |
2015 |
California |
Building Capacity for the Clinical Trials Office at Children's Hospital of Wisconsin - Strengthening Phase I & II Trials Infrastructure |
Children's Hospital of Wisconsin - Milwaukee / Michael J. Burke, MD |
Phase I/II Infrastructure Grants |
2015 |
Wisconsin |
Expanding Innovative Pediatric Cancer Clinical Trial Access at Stanford |
Stanford University / Maria-Grazia Roncarolo, M.D. & Sherri Spunt, M.D. |
Phase I/II Infrastructure Grants |
2015 |
California |
Phase I and II Clinical Research Program Infrastructure Award |
University of Minnesota / Brenda Weigel, MD & Emily Greengard MD |
Phase I/II Infrastructure Grants |
2015 |
Minnesota |
DNA Sequencing Using Malaria Slides |
Indiana University / Terry Vik, MD |
Epidemiology Grants |
2015 |
Indiana |
Space-Time Analysis of the California Birth Cohort: 30 Years of Childhood Cancer |
University of California Berkeley / Steve Selvin, PhD |
Epidemiology Grants |
2015 |
California |